2024-06 |
Developing a comprehensive molecular subgrouping model for cervical cancer using machine learning |
American Journal of Cancer Research
|
2024-05 |
Serum Lipidome Profiling Reveals a Distinct Signature of Ovarian Cancer in Korean Women |
Cancer Epidemiology Biomarkers and Prevention
|
2024-03 |
Comparison of Adverse Events Between PARP Inhibitors in Patients with Epithelial Ovarian Cancer: A Nationwide Propensity Score Matched Cohort Study |
Targeted Oncology
|
2023-10 |
Ascitic autotaxin as a potential prognostic, diagnostic, and therapeutic target for epithelial ovarian cancer |
British Journal of Cancer
|
2023-05 |
Nectin-4 as a Predictive Marker for Poor Prognosis of Endometrial Cancer with Mismatch Repair Impairment |
Cancers
|
2023-05 |
TRPV1 inhibition overcomes cisplatin resistance by blocking autophagy-mediated hyperactivation of EGFR signaling pathway |
Nature communications
|
2023-05 |
High ATP6V1B1 expression is associated with poor prognosis and platinum‑based chemotherapy resistance in epithelial ovarian cancer |
Oncology reports
|
2023-03 |
Prognostic value of β-Arrestins in combination with glucocorticoid receptor in epithelial ovarian cancer |
Frontiers in Oncology
|
2023-02 |
High-Dose Selenium Induces Ferroptotic Cell Death in Ovarian Cancer
|
International Journal of Molecular Sciences
|
2022-11 |
TMED9 Expression Level as a Biomarker of Epithelial Ovarian Cancer Progression and Prognosis |
Cancer Genomics and Proteomics
|
2022-11 |
RNA sequencing and bioinformatics analysis revealed PACSIN3 as a potential novel biomarker for platinum resistance in epithelial ovarian cancer |
JOURNAL OF GENE MEDICINE
|
2022-10 |
NANOG regulates epithelial-mesenchymal transition via AMPK/mTOR signalling pathway in ovarian cancer SKOV-3 and A2780 cells |
Journal of Cellular and Molecular Medicine
|
2022-07 |
Overexpression of glucocorticoid receptor promotes the poor progression and induces cisplatin resistance through p38 MAP kinase in cervical cancer patients |
AMERICAN JOURNAL OF CANCER RESEARCH
|
2022-05 |
NANOG confers resistance to complement-dependent cytotoxicity in immune-edited tumor cells through up-regulating CD59 |
SCIENTIFIC REPORTS
|
2022-02 |
Identification of Prognostic Markers of Gynecologic Cancers Utilizing Patient-Derived Xenograft Mouse Models |
Cancers
|
2021-11 |
CRY1 Regulates Chemoresistance in Association With NANOG by Inhibiting Apoptosis via STAT3 Pathway in Patients With Cervical Cancer |
CANCER GENOMICS & PROTEOMICS
|
2021-07 |
Modulated electro-hyperthermia with weekly paclitaxel or cisplatin in patients with recurrent or persistent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: The KGOG 3030 trial |
EXPERIMENTAL AND THERAPEUTIC MEDICINE
|
2021-05 |
Clinical significance of tumor infiltrating lymphocytes in association with hormone receptor expression patterns in epithelial ovarian cancer |
International Journal of Molecular Sciences
|
2021-05 |
The Combination of Transient Receptor Potential Vanilloid Type 1 (TRPV1) and Phosphatase and Tension Homolog (PTEN) is an Effective Prognostic Biomarker in Cervical Cancer |
INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
|
2021-04 |
LC3B upregulation by NANOG promotes immune resistance and stem-like property through hyperactivation of EGFR signaling in immune-refractory tumor cells |
AUTOPHAGY
|
2021-01 |
MEK/ERK signaling is a critical regulator of high-risk human papillomavirus oncogene expression revealing therapeutic targets for HPV-induced tumors |
PLOS PATHOGENS
|
2020-05 |
TOM40 inhibits ovarian cancer cell growth by modulating mitochondrial function including intracellular ATP and ROS levels |
Cancers
|
2020-05 |
Prognostic Significance of Transient Receptor Potential Vanilloid Type 1 (TRPV1) and Phosphatase and Tension Homolog (PTEN) in Epithelial Ovarian Cancer |
CANCER GENOMICS & PROTEOMICS
|
2020-01 |
HSP90A inhibition promotes anti-tumor immunity by reversing multi-modal resistance and stem-like property of immune-refractory tumors |
NATURE COMMUNICATIONS
|
2019-12 |
Prognostic implications of forkhead box protein O1 (FOXO1) and paired box 3 (PAX3) in epithelial ovarian cancer |
BMC CANCER
|
2019-11 |
Loss of Both USP10 and p14ARF Protein Expression Is an Independent Prognostic Biomarker for Poor Prognosis in Patients With Epithelial Ovarian Cancer |
CANCER GENOMICS & PROTEOMICS
|
2019-11 |
Forkhead box protein O1 (FOXO1) and paired box gene 3 (PAX3) overexpression is associated with poor prognosis in patients with cervical cancer |
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY
|
2019-10 |
ALDH1A2 Is a Candidate Tumor Suppressor Gene in Ovarian Cancer |
Cancers
|
2019-06 |
Combined treatment with modulated electro-hyperthermia and an autophagy inhibitor effectively inhibit ovarian and cervical cancer growth |
INTERNATIONAL JOURNAL OF HYPERTHERMIA
|
2018-10 |
Establishment of five immortalized human ovarian surface epithelial cell lines via SV40 T antigen or HPV E6/E7 expression |
PLOS ONE
|
2018-08 |
Mitochondrial reprogramming via ATP5H loss promotes multimodal cancer therapy resistance |
JOURNAL OF CLINICAL INVESTIGATION
|
2018-08 |
DNA mismatch repair protein immunohistochemistry and MLH1 promotor methylation testing for practical molecular classification and the prediction of prognosis in endometrial cancer |
Cancers
|
2018-07 |
Comparison of Clinical Features and Outcomes in Epithelial Ovarian Cancer according to Tumorigenicity in Patient-Derived Xenograft Models. |
CANCER RESEARCH AND TREATMENT
|
2018-05 |
Preoperative serum levels of cancer antigen 125 and carcinoembryonic antigen ratio can improve differentiation between mucinous ovarian carcinoma and other epithelial ovarian carcinomas |
Obstetrics & Gynecology Science
|
2018-05 |
Prognostic implication of programmed cell death 1 protein and its ligand expressions in endometrial cancer. |
GYNECOLOGIC ONCOLOGY
|
2018-05 |
Targeting Cyclin D-CDK4/6 Sensitizes Immune-Refractory Cancer by Blocking the SCP3-NANOG Axis |
CANCER RESEARCH
|
2018-02 |
Histomorphological and Molecular Assessments of the Fixation Times Comparing Formalin and Ethanol-Based Fixatives |
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
|
2018-02 |
Oncogene-induced senescence mediated by c-Myc requires USP10 dependent deubiquitination and stabilization of p14ARF |
CELL DEATH AND DIFFERENTIATION
|
2017-09 |
API5 induces cisplatin resistance through FGFR signaling in human cancer cells |
EXPERIMENTAL AND MOLECULAR MEDICINE
|
2017-09 |
HDAC1 Upregulation by NANOG Promotes Multidrug Resistance and a Stem-like Phenotype in Immune Edited Tumor Cells. |
CANCER RESEARCH
|
2017-09 |
Bcl-2-like Protein 11 (BIM) Expression Is Associated with Favorable Prognosis for Patients with Cervical Cancer |
ANTICANCER RESEARCH
|
2017-01 |
REP1 inhibits FOXO3-mediated apoptosis to promote cancer cell survival |
CELL DEATH & DISEASE
|
2017-01 |
Practice guidelines for management of uterine corpus cancer in Korea: a Korean Society of Gynecologic Oncology Consensus Statement |
JOURNAL OF GYNECOLOGIC ONCOLOGY
|
2016-10 |
A melanin-bleaching methodology for molecular and histopathological analysis of formalin-fixed paraffin-embedded tissue. |
LABORATORY INVESTIGATION
|
2016-07 |
Accumulation of cytoplasmic Cdk1 is associated with cancer growth and survival rate in epithelial ovarian cancer |
ONCOTARGET
|
2016-05 |
The paraffin-embedded RNA metric (PERM) for RNA isolated from formalin-fixed, paraffin-embedded tissue |
BIOTECHNIQUES
|
2016-05 |
Clinical Significance of CA125 Level after the First Cycle of Chemotherapy on Survival of Patients with Advanced Ovarian Cancer |
YONSEI MEDICAL JOURNAL
|
2016-02 |
Over-expression of BMI1 is associated with favorable prognosis in cervical cancer |
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY
|
2016-01 |
Makorin Ring Finger Protein 1 as Adjunctive Marker in Liquid-based Cervical Cytology |
MEDICINE
|
2015-12 |
Clinical significance of OCT4 and SOX2 protein expression in cervical cancer |
BMC CANCER
|
2015-11 |
Prognostic role and implications of mutation status of tumor suppressor gene ARID1A in cancer: a systematic review and meta-analysis. |
ONCOTARGET
|
2015-10 |
Prognostic Significance of AMP-Dependent Kinase Alpha Expression in Cervical Cancer |
PATHOBIOLOGY
|
2015-07 |
PI3K/AKT activation induces PTEN ubiquitination and destabilization accelerating tumourigenesis. |
NATURE COMMUNICATIONS
|
2015-05 |
Assessment of a panel of tumor markers for the differential diagnosis of benign and malignant effusions by well-based reverse phase protein array |
DIAGNOSTIC PATHOLOGY
|
2014-12 |
MICA/B and ULBP1 NKG2D ligands are independent predictors of good prognosis in cervical cancer. |
BMC CANCER
|
2014-11 |
ATP-Based Chemotherapy Response Assay in Primary or Recurrent Ovarian and Peritoneal Cancer |
YONSEI MEDICAL JOURNAL
|
2014-09 |
A Phase 2 Trial of Radiation Therapy With Concurrent Paclitaxel Chemotherapy After Surgery in Patients With High-Risk Endometrial Cancer: A Korean Gynecologic Oncologic Group Study |
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
|
2014-07 |
Apoptosis inhibitor-5 overexpression is associated with tumor progression and poor prognosis in patients with cervical cancer |
BMC CANCER
|
2014-06 |
The role of S100A14 in epithelial ovarian tumors |
ONCOTARGET
|
2014-06 |
Synaptonemal Complex Protein 3 Is a Prognostic Marker in Cervical Cancer |
PLOS ONE
|
2014-04 |
Expression of Stress-Induced Phosphoprotein1 (STIP1) is Associated with Tumor Progression and Poor Prognosis in Epithelial Ovarian Cancer |
GENES CHROMOSOMES & CANCER
|
2013-11 |
Downregulation of ERp57 expression is associated with poor prognosis in early-stage cervical cancer |
BIOMARKERS
|
2013-11 |
Overexpression of Glucose Transporter-1 (GLUT-1) Predicts Poor Prognosis in Epithelial Ovarian Cancer. |
CANCER INVESTIGATION
|
2013-08 |
Prognostic assessment of hypoxia and metabolic markers in cervical cancer using automated digital image analysis of immunohistochemistry. |
JOURNAL OF TRANSLATIONAL MEDICINE
|
2013-07 |
Loss of ARID1A/BAF250a expression is linked to tumor progression and adverse prognosis in cervical cancer. |
HUMAN PATHOLOGY
|
2013-04 |
Synaptonemal complex protein 3 as a novel prognostic marker in early stage non-small cell lung cancer |
HUMAN PATHOLOGY
|
2013-03 |
The ON-Q pain management system in elective gynecology oncologic surgery: Management of postoperative surgical site pain compared to intravenous patient-controlled analgesia |
Obstetrics & Gynecology Science
|
2013-02 |
Clinical significance of serum anti-human papillomavirus 16 and 18 antibodies in cervical neoplasia |
OBSTETRICS AND GYNECOLOGY
|
2012-11 |
Nanog signaling in cancer promotes stem-like phenotype and immune evasion |
JOURNAL OF CLINICAL INVESTIGATION
|
2012-01 |
Pre-treatment diagnosis of endometrial cancer through a combination of CA125 and multiplication of neutrophil and monocyte |
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
|
2012-01 |
Human chorionic gonadotrophin regression rate as a predictive factor of postmolar gestational trophoblastic neoplasm in high-risk hydatidiform mole: A case-control study |
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY
|
2011-12 |
로봇을 이용한 자궁근종절제술의 유용성: 복강경 그리고 개복수술과 비교 |
대한산부인과학회지
|